Impact of delayed initiation of erythropoietin in critically ill patients

BACKGROUND: The purpose of this study was to evaluate the impact of recombinant human erythropoietin (rHuEPO) use for anemia of critical illness at a practice site where delayed initiation is common. METHODS: Retrospective medical record review involving patients treated with rHuEPO for anemia of cr...

Descripción completa

Detalles Bibliográficos
Autores principales: Duby, Jeremiah J, Erstad, Brian L, Abarca, Jacob, Camamo, James M, Huckleberry, Yvonne, Bramblett, Stuart N
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077862/
https://www.ncbi.nlm.nih.gov/pubmed/17916251
http://dx.doi.org/10.1186/1471-2326-7-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2077862/
https://www.ncbi.nlm.nih.gov/pubmed/17916251
http://dx.doi.org/10.1186/1471-2326-7-1

Ejemplares similares